Literature DB >> 15717161

Role of urinary supersaturation in the evaluation of children with urolithiasis.

Marc B Lande1, William Varade, Elif Erkan, Yvonne Niederbracht, George J Schwartz.   

Abstract

Timed urine collections are a standard part of the evaluation for predisposition to stone formation in children with urolithiasis. Supersaturation is defined as the ratio of the concentration of dissolved salt to its solubility in urine. The purpose of the present study was to determine if adding supersaturation to the standard timed urine collection increased the ability to detect a metabolic predisposition to stone formation. Thirty-two children with urolithiasis had 24-hour urine measurements of calcium, oxalate, citrate, uric acid, and cystine (the "traditional" evaluation), as well as supersaturation for calcium oxalate, calcium phosphate, and uric acid, on the same urine sample. Nine (28%) of the 32 were hypercalciuric, 2 (6%) hyperoxaluric, and 4 (12%) hypocitraturic. In total, 14 (44%) had a metabolic predisposition that was detected by the traditional evaluation. Supersaturation was elevated in 18 (56%), including nine who did not have metabolic predisposition detected by traditional evaluation. Urine volume was low in 17 (53%) of 32 children, including eight of nine children with abnormal supersaturation but normal traditional evaluation. Only one child with normal traditional evaluation and normal urine volume had elevated supersaturation. These results show that the benefit of adding supersaturation to the traditional evaluation was largely negated by consideration of urine volume.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717161     DOI: 10.1007/s00467-004-1779-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  13 in total

1.  Divergence between stone composition and urine supersaturation: clinical and laboratory implications.

Authors:  J Lingeman; R Kahnoski; H Mardis; D S Goldfarb; M Grasso; S Lacy; S J Scheinman; J R Asplin; J H Parks; F L Coe
Journal:  J Urol       Date:  1999-04       Impact factor: 7.450

2.  Proportional reduction of urine supersaturation during nephrolithiasis treatment.

Authors:  F L Coe; H Wise; J H Parks; J R Asplin
Journal:  J Urol       Date:  2001-10       Impact factor: 7.450

Review 3.  Childhood stones.

Authors:  F Bruder Stapleton
Journal:  Endocrinol Metab Clin North Am       Date:  2002-12       Impact factor: 4.741

4.  Urinary calcium oxalate saturation in healthy infants and children.

Authors:  B Hoppe; A Jahnen; D Bach; A Hesse
Journal:  J Urol       Date:  1997-08       Impact factor: 7.450

5.  EQUIL2: a BASIC computer program for the calculation of urinary saturation.

Authors:  P G Werness; C M Brown; L H Smith; B Finlayson
Journal:  J Urol       Date:  1985-12       Impact factor: 7.450

Review 6.  Renal stones and hypercalciuria.

Authors:  M S Polinsky; B A Kaiser; H J Baluarte; A B Gruskin
Journal:  Adv Pediatr       Date:  1993

Review 7.  Renal stone disease in children.

Authors:  M Santos-Victoriano; B H Brouhard; R J Cunningham
Journal:  Clin Pediatr (Phila)       Date:  1998-10       Impact factor: 1.168

8.  Clinical experience with pediatric urolithiasis.

Authors:  H N Noe; F B Stapleton; G R Jerkins; S Roy
Journal:  J Urol       Date:  1983-06       Impact factor: 7.450

9.  Urolithiasis in pediatric patients.

Authors:  D S Milliner; M E Murphy
Journal:  Mayo Clin Proc       Date:  1993-03       Impact factor: 7.616

10.  Evaluation and treatment of pediatric idiopathic urolithiasis-revisited.

Authors:  Uri S Alon; Hannah Zimmerman; Michal Alon
Journal:  Pediatr Nephrol       Date:  2004-03-11       Impact factor: 3.714

View more
  19 in total

Review 1.  Pediatric urolithiasis: causative factors, diagnosis and medical management.

Authors:  Funda Baştuğ; Ruhan Düşünsel
Journal:  Nat Rev Urol       Date:  2012-02-07       Impact factor: 14.432

2.  Incidence of kidney stone disease in Icelandic children and adolescents from 1985 to 2013: results of a nationwide study.

Authors:  Vidar O Edvardsson; Solborg E Ingvarsdottir; Runolfur Palsson; Olafur S Indridason
Journal:  Pediatr Nephrol       Date:  2018-04-06       Impact factor: 3.714

Review 3.  The association between bacteria and urinary stones.

Authors:  Andrew L Schwaderer; Alan J Wolfe
Journal:  Ann Transl Med       Date:  2017-01

4.  Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones.

Authors:  Carmen Inés Rodriguez Cuellar; Peter Zhan Tao Wang; Michael Freundlich; Guido Filler
Journal:  Pediatr Nephrol       Date:  2019-01-04       Impact factor: 3.714

5.  Pediatric primary urolithiasis: Symptoms, medical management and prevention strategies.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2015-09-06

6.  Ecological Momentary Assessment of Factors Associated with Water Intake among Adolescents with Kidney Stone Disease.

Authors:  Gregory E Tasian; Michelle Ross; Lihai Song; Janet Audrain-McGovern; Douglas Wiebe; Steven G Warner; Brittney Henderson; Anisha Patel; Susan L Furth
Journal:  J Urol       Date:  2019-03       Impact factor: 7.450

7.  Demographic characteristics and metabolic risk factors in Croatian children with urolithiasis.

Authors:  Danko Milošević; Danica Batinić; Daniel Turudić; Danko Batinić; Marija Topalović-Grković; Ivan Pavao Gradiški
Journal:  Eur J Pediatr       Date:  2013-10-06       Impact factor: 3.183

Review 8.  Current medical treatment in pediatric urolithiasis.

Authors:  Yiğit Akın; Murat Uçar; Selçuk Yücel
Journal:  Turk J Urol       Date:  2013-12

9.  Risk factors for urinary stones in healthy schoolchildren with and without a family history of nephrolithiasis.

Authors:  Concepción Sáez-Torres; Félix Grases; Dolores Rodrigo; Ana María García-Raja; Cristina Gómez; Guillem Frontera
Journal:  Pediatr Nephrol       Date:  2012-12-02       Impact factor: 3.714

Review 10.  Medical treatment of pediatric urolithiasis.

Authors:  Uri S Alon
Journal:  Pediatr Nephrol       Date:  2008-02-14       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.